Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2001, Vol. 6 ›› Issue (1): 1-4.

    Next Articles

Effect of bcl-2 antisense oligonucleotide targeting different region of bcl-2 mRNA on drug-sensitivity of leukemia cells1

LEI Xiao-Yong, ZHANG Huan   

  1. Department of hematology, Jinan University, Guanzhou 510632
  • Received:2000-11-22 Online:2001-02-26 Published:2020-12-01

Abstract: Aim To explore the effects of bcl-2 antisense oligonucleotide targeting the coding region of the bcl-2 mRNA on apoptosis induced by Vp16 in HL60 and K 562 cells. Methods Drug sensitivity was compared by MTTcy to toxicity assay, and expression of bcl-2 protein and apototic cells were assayed by flow cytometry. Results The bcl-2 antisense oligonucleotide of 10 μmol·L-1 combined with etoposide inhibited expression of bcl-2 protein, increased apoptosis in HL60 and K 562 cells and decreased IC50 of etoposide; The antisense oligonucleotide targeting the coding region of the bcl-2 mRNA had stronger effection than the antisense oligonucleotide targeting the translation initiation. Conclusion The bcl-2 antisense oligonucleotide targeting the codingregion of the bcl-2 mRNA can enhances etopo side induced apoptosis of HL60 and K 562 cells.

Key words: antisense oligonucleotide, bcl-2, leukemia cells, etoposide, drug sensitivity

CLC Number: